Mimedx (MDXG) FCF Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,659.00 |
| Dec 31, 2025 | 3,901.00 |
| Sep 30, 2025 | 3,382.00 |
| Jun 30, 2025 | 2,098.00 |
| Mar 31, 2025 | 2,711.00 |
| Dec 31, 2024 | 5,211.00 |
| Sep 30, 2024 | 2,577.00 |
| Jun 30, 2024 | 2,317.00 |
| Mar 31, 2024 | 2,961.00 |
| Dec 31, 2023 | 984.00 |
| Sep 30, 2023 | 1,524.00 |
| Jun 30, 2023 | -989.00 |
| Mar 31, 2023 | -1,498.00 |
| Dec 31, 2022 | -1,758.00 |
| Sep 30, 2022 | -1,573.00 |
| Jun 30, 2022 | -2,181.00 |
| Mar 31, 2022 | -3,301.00 |
| Dec 31, 2021 | -5,101.00 |
| Sep 30, 2021 | 715.00 |
| Jun 30, 2021 | -790.00 |
| Mar 31, 2021 | -878.00 |
| Dec 31, 2020 | -2,334.00 |
| Sep 30, 2020 | -1,971.00 |
| Jun 30, 2020 | -1,041.00 |
| Mar 31, 2020 | -2,855.00 |
| Dec 31, 2019 | -4,588.00 |
| Sep 30, 2019 | -3,035.00 |
| Jun 30, 2019 | -171.00 |
| Mar 31, 2019 | -1,549.00 |
| Dec 31, 2018 | -1,584.00 |
| Sep 30, 2018 | -325.00 |
| Jun 30, 2018 | 3,193.00 |
| Mar 31, 2018 | 2,724.00 |
| Dec 31, 2017 | 3,299.00 |
| Sep 30, 2017 | 2,952.00 |
| Jun 30, 2017 | 2,799.00 |
| Mar 31, 2017 | 5,020.00 |
| Dec 31, 2016 | 10,975.00 |
| Sep 30, 2016 | 4,598.00 |
| Jun 30, 2016 | 12,166.00 |
| Mar 31, 2016 | 17,666.00 |